Pronto Diagnostics
MNG Signs Israeli Distribution Deal With Pronto Diagnostics
The deal covers MNG's complete line of neurogenetic clinical RNA sequencing services, including complete transcriptome sequencing.
Pronto Diagnostics Plans to Integrate FDNA's Phenotypic Analysis Into Its Genetic Tests
The Israeli molecular diagnostics company will use artificial intelligence and phenotypic analysis to increase the diagnostic rate of its genetic tests.
Tel Aviv University Taps Capture/Sequencing Method to Diagnose Hearing Loss in Local Populations
Premium
By Molika Ashford
In the hunt for the genetic causes of hearing loss in local populations, researchers at Tel Aviv University have taken up targeted genomic capture and deep sequencing to root out causative mutations.
Pronto Diagnostics to Distribute Vermillion's OVA Test in Israel, Palestinian Territories
Pronto will begin offering the test to the private payor market and begin the regulatory process to make the test available to the publicly funded Israeli HMO market.
Pronto to Distribute Signal's Myeloma Test
Signal Genetics' CEO J said the deal "represents our initial entry into the international market with MyPRS and strong interest among both laboratories and physicians outside the United States in providing broader access to this novel technology."